Modified Pfeffer Questionnaire for Functional Assessment in Parkinson Disease

Carregando...
Imagem de Miniatura
Citações na Scopus
7
Tipo de produção
article
Data de publicação
2017
Título da Revista
ISSN da Revista
Título do Volume
Editora
SAGE PUBLICATIONS INC
Autores
MACEDO, Livio Pereira de
LOPES, Janine Lemos de Melo Lobo Jofili
CAMPOS-SOUSA, Raimundo Nonato
Citação
JOURNAL OF GERIATRIC PSYCHIATRY AND NEUROLOGY, v.30, n.5, p.261-266, 2017
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Introduction: It was proposed to modify the Pfeffer questionnaire (PQ) for functional assessment in patients with Parkinson disease (PD). Aim: To determine the cutoff score for diagnosis of functional impairment in patients with PD by modified PQ (mPQ). Methods: A total of 110 patients with PD were enrolled into the study, and a neuropsychological test battery was performed to assess their cognitive status. Regarding functional assessment, the mPQ has been applied, and their results were compared to the functional assessment by Informant Questionnaire on Cognitive Decline in the Elderly adapted for use in Brazil (IQCODE-BR). The statistical analysis was accomplished through receiver operating characteristic (ROC) curve with evaluation of the area under the curve, sensitivity, and specificity of the new cutoff point. Results: Eighty-nine patients with PD were evaluated with a mean age of 63.69 +/- 9.14 years. Cognitive status categorization was 28.10% as normal, 44.94% as mild cognitive impairment, and 26.96% of patients as dementia associated with PD. The average score on PQ was 3.49 +/- 4.79 and on the mPQ 2.56 +/- 3.49. In IQCODE-BR, the average score was 6.75 +/- 32.72. The ROC curve for the new cutoff point presented 47.4% sensitivity, 88.10% specificity, and 0.757 of area under the curve, with a standard deviation of 0.055 (95% confidence interval: 0.650-0.864). Conclusion: 3.5 is proposed as the cutoff point to define functional impairment in patients with PD by mPQ.
Palavras-chave
Parkinson disease, questionnaires, cognition
Referências
  1. Aarsland D, 2003, ARCH NEUROL-CHICAGO, V60, P387, DOI 10.1001/archneur.60.3.387
  2. Tedrus GMAS, 2009, ARQ NEURO-PSIQUIAT, V67, P423, DOI 10.1590/S0004-282X2009000300010
  3. Bohnen NI, 2007, J NEUROL, V254, P84, DOI 10.1007/s00415-006-0284-y
  4. Comella CL, 2006, J NEURAL TRANSM-SUPP, P349
  5. COOPER JA, 1991, BRAIN, V114, P2095, DOI 10.1093/brain/114.5.2095
  6. Cummings JL, 1999, INT J GERIATR PSYCH, V14, P711, DOI 10.1002/(SICI)1099-1166(199909)14:9<711::AID-GPS4>3.0.CO;2-1
  7. de Lau LML, 2005, ARCH NEUROL-CHICAGO, V62, P1265, DOI 10.1001/archneur.62.8.1265
  8. dos Santos AA, 2011, ACTA PAUL ENFERM, V24, P520, DOI 10.1590/S0103-21002011000400012
  9. Dubois B, 2007, MOVEMENT DISORD, V22, P2314, DOI 10.1002/mds.21844
  10. Dutra Marina Carneiro, 2015, Dement. neuropsychol., V9, P176, DOI 10.1590/1980-57642015DN92000012
  11. Emre M, 2007, MOVEMENT DISORD, V22, P1689, DOI 10.1002/mds.21507
  12. Foltynie T, 2004, BRAIN, V127, P550, DOI 10.1093/brain/awh067
  13. Freitas S., 2010, AVAL PSICOL, V9, P345
  14. Hobson P, 2004, MOVEMENT DISORD, V19, P1043, DOI 10.1002/mds.20216
  15. Huang XM, 2006, ARCH NEUROL-CHICAGO, V63, P189, DOI 10.1001/archneur.63.2.189
  16. JORM AF, 1988, BRIT J PSYCHIAT, V152, P209, DOI 10.1192/bjp.152.2.209
  17. Jorm AF, 2004, INT PSYCHOGERIATR, V16, P275, DOI 10.1017/S1041610204000390
  18. Kempster PA, 2007, NEUROLOGY, V69, P482, DOI 10.1212/01.wnl.0000266639.50620.d1
  19. Lemke MR, 2004, J NEUROL, V251, P24, DOI 10.1007/s00415-004-1606-6
  20. Levy G, 2002, MOVEMENT DISORD, V17, P1221, DOI 10.1002/mds.10280
  21. Litvan I, 2012, MOVEMENT DISORD, V27, P349, DOI 10.1002/mds.24893
  22. Lucetti C, 2006, PARKINSONISM RELAT D, V12, P279, DOI 10.1016/j.parkreldis.2005.12.005
  23. Melo LM, 2007, REV PSIQUIATRIA CLIN, V34, P176
  24. Pedersen KF, 2013, JAMA NEUROL, V70, P580, DOI 10.1001/jamaneurol.2013.2110
  25. PFEFFER RI, 1982, J GERONTOL, V37, P323, DOI 10.1093/geronj/37.3.323
  26. Sanchez Maria Angélica dos Santos, 2011, Dement. neuropsychol., V5, P322, DOI 10.1590/S1980-57642011DN05040010
  27. Sanchez MAD, 2009, CAD SAUDE PUBLICA, V25, P1455, DOI 10.1590/S0102-311X2009000700003
  28. Thanvi BR, 2004, POSTGRAD MED J, V80, P452, DOI 10.1136/pgmj.2003.013912
  29. Todorova Antoniya, 2014, Pract Neurol, V14, P310, DOI 10.1136/practneurol-2013-000741
  30. Watson GS, 2010, BRAIN PATHOL, V20, P640, DOI 10.1111/j.1750-3639.2010.00373.x
  31. Wullner U, 2007, EUR J NEUROL, V14, P1405, DOI 10.1111/j.1468-1331.2007.01982.x
  32. Xia RP, 2012, NEUROSCI BULL, V28, P39, DOI 10.1007/s12264-012-1050-z